Skip to content
Home/Companies/Biotech/Lipofabrik

Lipofabrik

Biotech·France·Exited 2022·Held 4yr
Entry
2018
Hold
4yr
Exit
2022

Who owns Lipofabrik?

Lipofabrik was owned by Re-Sources Capital through Re-Sources Capital (2014 vintage) from 2018 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-11

Re-Sources Capital
Investor
Re-Sources Capital
Re-Sources Capital · 2014 · Buyout

Key facts

HQFrance
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from Re-Sources Capital

Other portfolio companies in the same fund.

Beyond Associes
Active
Business ServicesFrance· 2026
Dealinka
Active
E-commerceFrance· 2026
Drotek
Active
Aerospace & DefenceFrance· 2026
Clareton
Active
LogisticsFrance· 2025
Elayon
Active
FoodTechFrance· 2025
Idem
Active
IT ServicesFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Lipofabrik

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Lipofabrik.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue